腹膜透析相关性腹膜炎致病菌的耐药性分析_West China Medical Journal

Authors：

唐勇 , 刘婕

Corresponding author：

Keywords：

腹膜透析; 腹膜炎; 抗生素; 抗药性

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

目的:探讨腹膜透析相关性腹膜炎的致病菌及其耐药性。方法:回顾性分析的93例腹膜透析相关性腹膜炎的致病菌及其耐药性。结果:34例培养阳性, 透出液培养阳性率为36.6%, 其中革兰阳性球菌14例, 革兰阴性杆菌17例, 真菌4例。革兰阴性杆菌对氨苄西林的耐药率最高,达83.3%,亚胺培南耐药性最低,达20.0%。革兰阳性球菌对青霉素、环丙沙星的耐药率高,分别为81.8%、71.4%。结论:提高腹膜透析液细菌培养阳性率有助于腹膜透析相关性腹膜炎的治疗;在经验用药基础上,应依据细菌培养、药敏,选择治疗腹膜透析相关性腹膜炎的敏感、有效抗菌素,真菌性腹膜炎治疗效果仍差,应尽早拔管。

Citation： 唐勇,刘婕. 腹膜透析相关性腹膜炎致病菌的耐药性分析. West China Medical Journal, 2009, 24(8): 2150-2151. doi: Copy

1.	PIRAINO B, BAILIE G R, BERNARDINI J, et al. Peritoneal dialysisrelated infections recommendations: 2005 update[J]. Perit Dial Int,2005,25(2):107-131.
2.	FRIED L F, BERNARDINI J, JOHNSTON J R, et al. Peritonitis influences mortality in peritoneal dialysis patients.[J]. J Am Soc Nephrol,1996,7(10):2176-2182.
3.	WIGGINS K J, JOHNSON D W, CRAIG J C, et al. Treatment of peritoneal dialysisassociated peritonitis: a systematic review of randomized controlled trials.[J]. Am J Kidney Dis,2007,50(6):967-988.
4.	董捷. 关于2005年ISPD腹膜透析相关感染诊治指南的几点思考[J]. 中国血液净化,2008(03):117-119.
5.	SZETO C C, CHOW K M, KWAN B C, et al. Staphylococcus aureus peritonitis complicates peritoneal dialysis: review of 245 consecutive cases.[J]. Clin J Am Soc Nephrol,2007,2(2):245251.
6.	PORT F K, HELD P J, NOLPH K D, et al. Risk of peritonitis and technique failure by CAPD connection technique: a national study.[J]. Kidney Int,1992,42(4):967-974.
7.	郭群英, 陈林, 阳晓, 等. 腹膜透析相关感染性腹膜炎致病菌及菌谱变化单个腹膜透析中心15年回顾分析[J]. 中华肾脏病杂志,2006(12):719-724.
8.	KRISHNAN M, THODIS E, IKONOMOPOULOS D, et al. Predictors of outcome following bacterial peritonitis in peritoneal dialysis.[J]. Perit Dial Int,2002,22(5):573-581.

1. PIRAINO B, BAILIE G R, BERNARDINI J, et al. Peritoneal dialysisrelated infections recommendations: 2005 update[J]. Perit Dial Int,2005,25(2):107-131.
2. FRIED L F, BERNARDINI J, JOHNSTON J R, et al. Peritonitis influences mortality in peritoneal dialysis patients.[J]. J Am Soc Nephrol,1996,7(10):2176-2182.
3. WIGGINS K J, JOHNSON D W, CRAIG J C, et al. Treatment of peritoneal dialysisassociated peritonitis: a systematic review of randomized controlled trials.[J]. Am J Kidney Dis,2007,50(6):967-988.
4. 董捷. 关于2005年ISPD腹膜透析相关感染诊治指南的几点思考[J]. 中国血液净化,2008(03):117-119.
5. SZETO C C, CHOW K M, KWAN B C, et al. Staphylococcus aureus peritonitis complicates peritoneal dialysis: review of 245 consecutive cases.[J]. Clin J Am Soc Nephrol,2007,2(2):245251.
6. PORT F K, HELD P J, NOLPH K D, et al. Risk of peritonitis and technique failure by CAPD connection technique: a national study.[J]. Kidney Int,1992,42(4):967-974.
7. 郭群英, 陈林, 阳晓, 等. 腹膜透析相关感染性腹膜炎致病菌及菌谱变化单个腹膜透析中心15年回顾分析[J]. 中华肾脏病杂志,2006(12):719-724.
8. KRISHNAN M, THODIS E, IKONOMOPOULOS D, et al. Predictors of outcome following bacterial peritonitis in peritoneal dialysis.[J]. Perit Dial Int,2002,22(5):573-581.

West China Medical Journal

腹膜透析相关性腹膜炎致病菌的耐药性分析

Abstract Full text Figures/Tables Video References Cited by

Format

Content